dronabinol has been researched along with Influenza, Human in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Blagev, DP; Callahan, SJ; Collingridge, DS; Dean, NC; Guidry, DW; Harris, D; Lanspa, MJ | 1 |
Chen, W; Crawford, R; Kaminski, NE; Kaplan, BL; Karmaus, PW | 1 |
2 other study(ies) available for dronabinol and Influenza, Human
Article | Year |
---|---|
Diagnosing EVALI in the Time of COVID-19.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Betacoronavirus; Bronchoscopy; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diagnosis, Differential; Dronabinol; Electronic Nicotine Delivery Systems; Female; Humans; Influenza, Human; Intensive Care Units; Lung; Lung Injury; Male; Middle Aged; Noninvasive Ventilation; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed; Vaping; Young Adult | 2020 |
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2.
Topics: Animals; Bronchoalveolar Lavage Fluid; Coculture Techniques; Dronabinol; Flow Cytometry; Humans; Inflammation; Influenza, Human; Mice; Mice, Inbred C57BL; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2013 |